Posted on: 15 June 2026, source: news-medical.net An eight-month-old baby from Israel has become the first human ever to receive an experimental gene therapy designed to replace a missing gene responsible for a devastating neurological disease that until now offered no hope of survival. The treatment was performed at Clalit-Schneider Children’s Medical Center, part of Clalit Health Services, Israel's largest health organization running 14 hospitals and 1600 community clinics nationwide. It took part after an extraordinary international effort involving physicians, researchers, regulators and biotech leaders who moved urgently to make the impossible possible for one small child. {fastsocialshare}